Literature DB >> 3162453

Long term survivors following treatment of childhood acute lymphoblastic leukaemia during 1970-75.

B M Carr, J P Rees, J B Healy, I J Temperley.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3162453     DOI： 10.1007/bf02953675

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  8 in total

Review 1.  The ninth annual David Karnofsky Lecture. Treatment of acute lymphocytic leukemia.

Authors:  D Pinkel
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

2.  A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia.

Authors:  R J Aur; J V Simone; H O Hustu; M S Verzosa
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

3.  Testicular infiltration in acute lymphoblastic leukaemia.

Authors:  H E Kay
Journal:  Br J Haematol       Date:  1983-04       Impact factor: 6.998

4.  A reappraisal of the results of stopping therapy in childhood leukemia.

Authors:  S L George; R J Aur; A M Mauer; J V Simone
Journal:  N Engl J Med       Date:  1979-02-08       Impact factor: 91.245

5.  A good prognosis group in childhood acute lymphoblastic leukaemia.

Authors:  R J Stockley; P Y Ahlquist; M G Mott
Journal:  Br J Haematol       Date:  1983-10       Impact factor: 6.998

6.  Differences in prognosis for boys and girls with acute lymphoblastic leukaemia.

Authors:  H Sather; D Miller; M Nesbit; R Heyn; D Hammond
Journal:  Lancet       Date:  1981-04-04       Impact factor: 79.321

7.  Long-term survival in childhood acute lymphocytic leukemia in Italy.

Authors:  F Mandelli; S Amadori; A Ceci; C Guazzelli; E Madon; A Marchi; G Masera; G Paolucci; L Zanesco
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

8.  Acute lymphoblastic leukaemia: four-year survivals old and new.

Authors:  R M Hardisty; M M Till; J Peto
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.